BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22314267)

  • 1. The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.
    Shiino A; Watanabe T; Shirakashi Y; Kotani E; Yoshimura M; Morikawa S; Inubushi T; Akiguchi I
    J Cereb Blood Flow Metab; 2012 May; 32(5):805-15. PubMed ID: 22314267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.
    Du AT; Schuff N; Laakso MP; Zhu XP; Jagust WJ; Yaffe K; Kramer JH; Miller BL; Reed BR; Norman D; Chui HC; Weiner MW
    Neurology; 2002 Jun; 58(11):1635-41. PubMed ID: 12058091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.
    Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW
    Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.
    Fein G; Di Sclafani V; Tanabe J; Cardenas V; Weiner MW; Jagust WJ; Reed BR; Norman D; Schuff N; Kusdra L; Greenfield T; Chui H
    Neurology; 2000 Dec; 55(11):1626-35. PubMed ID: 11113215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
    Jones RS; Waldman AD
    Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer's disease in patients with only mild white matter alterations on T2-weighted images.
    Fu JL; Zhang T; Chang C; Zhang YZ; Li WB
    Acta Radiol; 2012 Apr; 53(3):312-7. PubMed ID: 22416261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia.
    Lam SM; Wang Y; Duan X; Wenk MR; Kalaria RN; Chen CP; Lai MK; Shui G
    Neurobiol Aging; 2014 Oct; 35(10):2369-81. PubMed ID: 24684787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
    Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.
    MacKay S; Ezekiel F; Di Sclafani V; Meyerhoff DJ; Gerson J; Norman D; Fein G; Weiner MW
    Radiology; 1996 Feb; 198(2):537-45. PubMed ID: 8596863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.
    Antuono PG; Jones JL; Wang Y; Li SJ
    Neurology; 2001 Mar; 56(6):737-42. PubMed ID: 11274307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease.
    Dixon RM; Bradley KM; Budge MM; Styles P; Smith AD
    Brain; 2002 Oct; 125(Pt 10):2332-41. PubMed ID: 12244089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging.
    Schuff N; Matsumoto S; Kmiecik J; Studholme C; Du A; Ezekiel F; Miller BL; Kramer JH; Jagust WJ; Chui HC; Weiner MW
    Alzheimers Dement; 2009 Nov; 5(6):454-62. PubMed ID: 19896584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.
    Capizzano AA; Schuff N; Amend DL; Tanabe JL; Norman D; Maudsley AA; Jagust W; Chui HC; Fein G; Segal MR; Weiner MW
    AJNR Am J Neuroradiol; 2000 Apr; 21(4):621-30. PubMed ID: 10782769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
    Catani M; Mecocci P; Tarducci R; Howard R; Pelliccioli GP; Mariani E; Metastasio A; Benedetti C; Senin U; Cherubini A
    J Am Geriatr Soc; 2002 Oct; 50(10):1707-10. PubMed ID: 12366626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.
    Lin Y; Yao J; Chen Y; Pang L; Li H; Cao Z; You K; Dai H; Wu R
    PLoS One; 2014; 9(2):e88562. PubMed ID: 24533108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.